Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Annji Pharmaceutical Co., Ltd. (7754) Income Statement

Annji Pharmaceutical Co., Ltd. Income Statement

Last quarter (Q2 2026), Annji Pharmaceutical Co., Ltd.'s total revenue was NT$540.00K, a decrease of 99.32% from the same quarter last year. In Q2, Annji Pharmaceutical Co., Ltd.'s net income was NT$-207.29M. See Annji Pharmaceutical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 7.55MNT$ 96.45MNT$ 143.53MNT$ 1.63MNT$ 1.44M
NT$ -43.90MNT$ 8.89MNT$ 18.44MNT$ 1.11MNT$ 976.00K
NT$ 325.46MNT$ 369.03MNT$ 287.06MNT$ 241.61MNT$ 203.25M
Depreciation and AmortizationNT$ 45.16MNT$ 44.95MNT$ 38.30MNT$ 40.42MNT$ 41.62M
NT$ -324.21MNT$ -315.19MNT$ -252.01MNT$ -194.60MNT$ -156.86M
NT$ -369.37MNT$ -360.14MNT$ -268.62MNT$ -240.50MNT$ -202.28M
NT$ 11.50MNT$ 6.16MNT$ -22.16MNT$ 5.44MNT$ 3.64M
NT$ -357.87MNT$ -353.99MNT$ -290.78MNT$ -235.06MNT$ -198.64M
NT$ -357.87MNT$ -353.99MNT$ -329.22MNT$ -236.65MNT$ -198.63M
Per Share Metrics
Basic EPSNT$ -3.78NT$ -3.81NT$ -4.25NT$ -3.61NT$ -4.39
Diluted EPSNT$ -3.78NT$ -3.81NT$ -4.25NT$ -3.61NT$ -4.39
Weighted Average Shares Outstanding94.62M92.89M77.40M65.55M45.20M
Weighted Average Shares Outstanding (Diluted)94.62M92.89M77.40M65.62M45.20M

Currency in TWD

Annji Pharmaceutical Co., Ltd. Earnings and Revenue History

-400M-200M0200M-18000 %-12000 %-6000 %0 %EarningsProfit Margin20212022202320242025RevenueEarningsProfit Margin